De Novo renal transplantation
Showing 51 - 75 of >10,000
Respiratory Tract Disease, Kidney Transplantation, Pediatric Trial in France (pulmonary function)
Recruiting
- Respiratory Tract Disease
- +2 more
- pulmonary function
-
Lille, France
- +4 more
Jun 17, 2021
Kidney Transplant Trial in Canada, United States (Abatacept, Standard of Care at US Transplant Centers)
Not yet recruiting
- Kidney Transplant
- Abatacept
- Standard of Care at US Transplant Centers
-
Birmingham, Alabama
- +19 more
Jun 20, 2023
Kidney Transplant; Complications, Diabetes Trial (Empagliflozin 25 MG, Linagliptin)
Not yet recruiting
- Kidney Transplant; Complications
- Diabetes Mellitus
- Empagliflozin 25 MG
- Linagliptin
- (no location specified)
Oct 18, 2023
Leukemia, MDS, Childhood Acute Myeloid Leukemia in Remission Trial in Minneapolis (biological, drug, procedure)
Recruiting
- Leukemia
- +12 more
- filgrastim
- +6 more
-
Minneapolis, MinnesotaMasonic Cancer Center, University of Minnesota
Jan 20, 2022
Hepatitis C, Transplantation Disease Transmission Trial in United States (Sofosbuvir/Velpatasvir,
Completed
- Hepatitis C
- Transplantation Disease Transmission
-
San Francisco, California
- +5 more
Feb 10, 2021
Kidney Transplantation Trial in Seoul (Sirolimus Tab., Mycophenolate Mofetil Cap./Tab.)
Not yet recruiting
- Kidney Transplantation
- Sirolimus Tab.
- Mycophenolate Mofetil Cap./Tab.
-
Seoul, Korea, Republic ofSeverance Hospital
Jan 6, 2021
Early Detection of de Novo Cancer in Liver Transplant Recipients
Completed
- De Novo Cancer
- Liver Transplant Disorder
- (no location specified)
Aug 5, 2022
Kidney Transplant Recipient Trial in Atlanta (Abatacept 125Mg/Ml Syringe)
Not yet recruiting
- Kidney Transplant Recipient
- Abatacept 125Mg/Ml Syringe
-
Atlanta, Georgia
- +1 more
Aug 2, 2023
Kidney Transplant Rejection Trial in Los Angeles (Extended-release tacrolimus, Immediate-release tacrolimus)
Recruiting
- Kidney Transplant Rejection
- Extended-release tacrolimus
- Immediate-release tacrolimus
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
Jan 18, 2022
Leukemia, Lymphoblastic, Acute, Philadelphia-Positive Trial in Valencia (dasatinib)
Completed
- Leukemia, Lymphoblastic, Acute, Philadelphia-Positive
-
Valencia, SpainHospital La Fe
Mar 16, 2022
Cardiovascular Risk, Chronic Kidney Disease, Inflammation Trial in Worldwide (Ziltivekimab, Placebo (ziltivekimab))
Recruiting
- Cardiovascular Risk
- +2 more
- Ziltivekimab
- Placebo (ziltivekimab)
-
Birmingham, Alabama
- +768 more
Dec 23, 2022
Liver Transplantation Trial in Hamburg (Treatment 2 weeks Envarsus followed by 2 weeks Advagraf, Treatment 2 weeks Advagraf
Completed
- Liver Transplantation
- Treatment 2 weeks Envarsus followed by 2 weeks Advagraf
- Treatment 2 weeks Advagraf followed by 2 weeks Envarsus
-
Hamburg, GermanyUniversity Hospital Hamburg-Eppendorf
May 3, 2021
Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With
Active, not recruiting
- Adult Acute Lymphoblastic Leukemia in Remission
- +14 more
- radiation therapy
- +8 more
-
Columbus, OhioArthur G. James Cancer Hospital and Solove Research Institute at
Oct 7, 2022
Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndrome, Myelodysplastic Syndrome Trial in Scottsdale, Cleveland,
Completed
- Chronic Myelomonocytic Leukemia
- +3 more
- Azacitidine
- +2 more
-
Scottsdale, Arizona
- +3 more
Jan 12, 2023
Kidney Transplant Immunosuppression Trial in China (Mizoribine, Mycophenolate Mofetil)
Recruiting
- Kidney Transplant Immunosuppression
- Mizoribine
- Mycophenolate Mofetil
-
Nanning, Guangxi, China
- +5 more
Oct 30, 2023
Kidney Transplant; Complications, CMV Trial (Letermovir 480 mg once daily, Historical/Control)
Not yet recruiting
- Kidney Transplant; Complications
- CMV
- Letermovir 480 mg once daily
- Historical/Control
- (no location specified)
Aug 14, 2023
Kidney Transplantation, Kidney Transplant Rejection Trial in Guangzhou
Not yet recruiting
- Kidney Transplantation
- Kidney Transplant Rejection
-
Guangzhou, Guangdong, ChinaThe First Affiliated Hospital, Sun Yat-sen University
Mar 19, 2023
Disorder Related to Renal Transplantation Trial in Jeonju, Seoul, Suwon (Tacrolimus(reduced), Mycophenolate mofetil(standard),
Completed
- Disorder Related to Renal Transplantation
- Tacrolimus(reduced), Mycophenolate mofetil(standard)
- Tacrolimus(standard), Mycophenolate mofetil(reduced)
-
Jeonju, Korea, Republic of
- +3 more
May 28, 2019
Lung Transplant; Complications Trial in Groningen (Extended release tacrolimus, Immediate release tacrolimus)
Recruiting
- Lung Transplant; Complications
- Extended release tacrolimus
- Immediate release tacrolimus
-
Groningen, NetherlandsUniversity medical center Groningen
Aug 12, 2021
Liver Disease Trial in Groningen, Leiden, Rotterdam (Tacrolimus and Sirolimus, Tacrolimus)
Completed
- Liver Disease
- Tacrolimus and Sirolimus
- Tacrolimus
-
Groningen, Netherlands
- +2 more
Mar 17, 2022
Belatacept to Delay Tacrolimus Initiation in Kidney Transplant
Active, not recruiting
- Belatacept Impact on Patients With GDF
- impact of administering one dose of belatacept on eGFR
-
Dallas, TexasMethodist Dallas Medical Center
Oct 17, 2023
Torquetenovirus Load in Chinese Renal Transplant Recipients
Not yet recruiting
- Kidney Transplant Rejection
- +3 more
-
Hangzhou, China
- +3 more
Feb 5, 2023
Frequency of APOL1 Gene Variants in Kidney Donors and Impact of
Recruiting
- To Measure the Prevalence of APOL1 Gene Variants in the Population of Living Kidney Donors
-
São Paulo, SP, BrazilHospital do Rim
Oct 31, 2023
De Novo Metabolic Syndrome in Liver Transplant Patients After
Completed
- Single Transplant
- 5 Years of Follow-up After Transplant, in Which an Attempt Was Made to Suspend IS
-
Rome, ItalyRoberta Angelico
Mar 29, 2023